Key Takeaways
- Shares of NBIS jumped approximately 8.95% during Wednesday’s session, reaching a new 52-week peak of $179.96
- The company announced plans to purchase Eigen AI for roughly $643 million to enhance its Token Factory AI capabilities
- A massive $27 billion agreement with Meta elevated the company’s total contracted backlog close to $50 billion
- Goldman Sachs increased its valuation target post-Meta announcement; Wall Street consensus stands at “Moderate Buy” with $154.75 average price target
- First quarter fiscal 2026 results scheduled for May 13, with focus on annual recurring revenue and Eigen integration milestones
Shares of Nebius Group (NBIS) began Wednesday’s trading at $175.92, climbing to an intraday peak of $179.96 and posting gains near 9%. The stock has now surged more than 110% since the start of the year.
This remarkable rally follows two significant announcements released in quick succession — the company’s $643 million agreement to purchase Eigen AI and a landmark $27 billion partnership with Meta.
The strategic acquisition of Eigen AI aims to integrate advanced model-optimization and inference technology into Nebius’s existing Token Factory infrastructure. Market analysts suggest this transaction could enhance profit margins while positioning the company to capture a greater share of enterprise AI deployment opportunities.
However, the Meta partnership represents the headline-grabbing development. This agreement, combined with previously established relationships with Microsoft and other major clients, has elevated Nebius’s total contracted backlog to approximately $50 billion. Such figures typically capture significant attention from institutional investors.
Goldman Sachs responded swiftly to the Meta announcement by revising its price target upward for NBIS. BWS Financial and DA Davidson have both established $200 price objectives with Buy recommendations. Cantor Fitzgerald launched coverage with an Overweight stance, albeit with a more measured $129 target. The overall Wall Street consensus remains at “Moderate Buy” with an average price target of $154.75.
Institutional activity has accelerated notably. Millennium Management established a fresh position valued at approximately $11.6 million during the first quarter. UBS contributed roughly $9 million in new holdings. Oppenheimer expanded its stake by 90.9% in the fourth quarter. Aggregate institutional ownership currently stands at about 21.9%.
Understanding the Backlog Momentum
The approximately $50 billion in contracted commitments forms the foundation of the bullish investment thesis. Long-term agreements with cloud infrastructure giants like Meta and Microsoft provide revenue predictability extending well into 2026, when the company projects revenue between $3.0 and $3.4 billion.
This level of forward revenue certainty is uncommon in the technology sector, explaining why momentum-focused investors have driven shares to unprecedented levels.
Potential Concerns and Headwinds
Despite the positive momentum, several issues warrant careful consideration. Operating cash flow for fiscal year 2025 reached approximately $402 million — however, this figure incorporated nearly $983 million in advance customer payments. Without these advances, the underlying cash generation appears considerably weaker.
Company leadership has acknowledged that contracted cash inflows will satisfy only about 60% of anticipated 2026 capital investment needs. This funding shortfall presents legitimate concerns regarding possible share dilution or additional debt financing.
Insider transaction activity has been notably heavy. Chief Technology Officer Danila Shtan divested over 13,000 shares in late March. Insider Andrey Korolenko sold more than 31,000 shares in early April. Collectively, company insiders have sold approximately 135,622 shares valued above $15.6 million over the past three months.
The stock also exhibits a beta coefficient of 4.03 — indicating extreme volatility in both upward and downward movements. With projected full-year earnings per share of -$2.44 and a price-to-earnings ratio of -120.49, the current valuation rests entirely on future growth expectations.
The company’s Q1 2026 financial results are scheduled for release on May 13. Investors will closely monitor annual recurring revenue trends, progress updates on hyperscaler infrastructure deployments, and preliminary indicators regarding the Eigen AI integration roadmap.





